Lung Adenocarcinoma Clinical Data with Effectiveness Scores
by Gregory C. Bloom·Updated 6y ago
Available on 1 platform
Sign in to view source links and access this dataset
Description
874 patients with adenocarcinoma of the lung, each with 47 clinical data elements, form the cohort for developing a novel effectiveness metric. The E-score metric, created by author Gregory C. Bloom, incorporates statistical p-values and quality A-scores to assess the utility of biomedical data elements. This dataset from 2020 provides the foundation for testing this metric, which ranks elements like age-at-diagnosis and tobacco-use based on both outcome correlation and data quality.
Use Cases
Analyze the relationship between an element's p-value for overall survival and its A-score for quality attributes like Completeness and Consistency.
Rank clinical data elements such as age-at-diagnosis, gender, and tobacco-use by their calculated E-score to prioritize data collection in research.
Investigate why elements like surgery-site and pathological-TNM stage have lower A-scores and E-scores despite potential statistical significance.
Validate the E-score metric's ability to down-rank elements with high acquisition costs, as demonstrated for histologic-type.
Strengths
The cohort consists of 874 patients, providing a substantive sample for analysis.
Each patient record includes 47 distinct clinical data elements, offering a multi-faceted view of lung adenocarcinoma cases.
The dataset is the basis for a peer-reviewed, novel methodology (E-score) that combines statistical and data quality metrics.
Limitations
The dataset is static and was last updated in 2020, potentially limiting its relevance to current clinical practices.
The cohort is specific to lung adenocarcinoma patients, limiting generalizability to other cancer types or diseases.
Without access to the raw columnar data or sample records, the exact structure and potential data issues are unknown.
Provenance
Source
Dryad digital repository.
Collection Method
Clinical data from a cohort of lung adenocarcinoma patients, with p-values calculated via Cox proportional hazard univariable regression and A-scores derived from quantifying four quality attributes.
Freshness
Static dataset last updated on 2020-06-24.
The dataset is associated with a specific methodological paper; users should review the accompanying publication to understand the E-score calculation fully. The data is shared under a CC0 1.0 Public Domain Dedication license.